TCON

TRACON Pharmaceuticals, Inc. Common Stock

Delisted

TCON was delisted on the 27th of June, 2024.

32 hedge funds and large institutions have $18.8M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$115K
Puts
$6K
Net Calls
Net Calls Change

Top Buyers

1 +$330K
2 +$79.1K
3 +$63.5K
4
Charles Schwab
Charles Schwab
California
+$42.8K
5
Citadel Advisors
Citadel Advisors
Florida
+$34.7K

Top Sellers

1 -$81.1K
2 -$67K
3 -$14.9K
4
TRCT
Tower Research Capital (TRC)
New York
-$9.3K
5
BlackRock
BlackRock
New York
-$4.04K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$9M
2
$5.23M
3
$1.12M
4
$860K
5
$578K
6
$489K
7
$319K
8
$295K
9
$159K
10
$142K
11
$126K
12
$109K
13
$79.1K
14
$42.8K
15
$41K
16
$37.8K
17
$34K
18
$32.1K
19
$24.6K
20
$22.3K
21
$22K
22
$19.5K
23
$11.4K
24
$6K
25
$3.78K